Marathon Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Marathon Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-500	Closed	-$3.74K	–	185
2026 Q2	$3.74K	Hold	500	–	–	﹤0.01%	187
2026 Q1	$5.66K	Buy	+500	New	+$6.82K	﹤0.01%	171

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Marathon Capital Management's CTSO Position: Q3 2026 in Review

Marathon Capital Management sold out of Cytosorbents Corp (CTSO) in Q3 2026, closing a stake of 500 shares — an estimated $3.74K sold.

Marathon Capital Management first reported a position in CTSO in Q1 2026 and held it in 2 quarters. The position peaked at $5.66K in Q1 2026. 2 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

Marathon Capital Management reported no remaining Cytosorbents Corp position as of Q3 2026 after selling out during the quarter.
Marathon Capital Management sold 500 Cytosorbents Corp shares in Q3 2026, an estimated $3.74K.
Marathon Capital Management first reported a position in Cytosorbents Corp in Q1 2026 and held it in 2 quarters.
Marathon Capital Management's Cytosorbents Corp position peaked at $5.66K in Q1 2026.
2 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on Marathon Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.